- Investing Ideas
- /
- U.S. Pharmaceuticals & Biotech Large Cap High Growth Potential
U.S. Pharmaceuticals & Biotech Large Cap High Growth Potential
UPDATED Apr 22, 2024
Large Cap Companies that analysts expect to have high earnings, revenue or cash flow growth in the next 3 years.
21 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
|---|---|---|---|---|---|---|---|---|---|---|
ALNY | US$145.79 | -0.6% | -27.9% | US$18.4b | US$220.00 | PS10.1x | E60.6% | n/a | ||
SGEN | US$228.74 | 4.5% | 76.5% | US$43.2b | US$228.91 | PS18.8x | E71.8% | n/a | ||
SRPT | US$116.96 | -0.3% | -5.1% | US$11.0b | US$164.54 | PS8.8x | E42.7% | n/a | ||
NBIX | US$133.66 | 0.5% | 30.6% | US$13.4b | US$152.48 | PE53.8x | E26.6% | n/a | ||
KRTX | US$329.83 | 3.3% | 80.7% | US$12.6b | US$326.92 | PS19238.9x | E60.1% | n/a | ||
LLY | US$731.33 | -2.1% | 90.0% | US$658.8b | US$813.32 | PE125.7x | E27.2% | 0.7% | ||
MEDP | US$376.26 | -2.3% | 80.7% | US$11.7b | US$402.04 | PE41.2x | E14.7% | n/a | ||
EXAS | US$62.41 | -2.3% | -1.8% | US$11.3b | US$89.27 | PS4.5x | E61.9% | n/a | ||
MRK | US$126.94 | 1.5% | 8.9% | US$321.5b | US$137.58 | PE880.9x | E25.9% | 2.4% | ||
ABBV | US$167.89 | 3.3% | 1.8% | US$297.3b | US$184.14 | PE61.7x | E23.4% | 3.7% | ||
INCY | US$51.92 | -2.4% | -29.4% | US$11.7b | US$75.68 | PE19.5x | E20.1% | n/a | ||
BGNE | US$130.94 | -2.3% | -46.9% | US$13.7b | US$268.64 | PS5.6x | E56.2% | n/a | ||
TEVA | US$12.88 | -1.6% | 56.5% | US$14.6b | US$15.74 | PB1.9x | E32.1% | 0% | ||
BMRN | US$89.49 | -1.5% | -6.4% | US$17.0b | US$110.42 | PE101.3x | E30.9% | n/a | ||
AVTR | US$24.41 | -0.8% | 29.4% | US$16.6b | US$27.80 | PE51.6x | E27.2% | n/a | ||
ILMN | US$120.25 | 2.2% | -45.0% | US$19.2b | US$158.58 | PS4.3x | E68.4% | n/a | ||
HZNP | US$116.30 | 0.06% | 82.8% | US$26.6b | US$116.50 | PE60.8x | E16.4% | n/a | ||
RVTY | US$100.77 | 0.5% | -21.0% | US$12.4b | US$123.05 | PE69.3x | E24.1% | 0.3% | ||
VRTX | US$399.92 | 1.5% | 20.5% | US$103.4b | US$460.34 | PE28.6x | E11.5% | n/a | ||
CTLT | US$56.05 | 0.5% | 32.3% | US$10.1b | US$63.50 | PS2.5x | E92.2% | n/a | ||
PFE | US$26.26 | 2.2% | -33.2% | US$148.7b | US$31.62 | PE69.7x | E22.1% | 6.4% |
Page 1 of 1